| Bashar Ericsoossi, MD | |
|
250 E Day Rd Ste 300, Mishawaka, IN 46545-3471 | |
| (574) 968-0283 | |
| (574) 968-0882 |
| Full Name | Bashar Ericsoossi |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 17 Years |
| Location | 250 E Day Rd Ste 300, Mishawaka, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437312758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 274622 (New York) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 01089928A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kidney Medical Associates Pllc | 5698071868 | 12 |
| Nephrology Physicians, Llc | 1850289273 | 10 |
News Archive
Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
Under a completely new way of providing health care, primary care clinicians in remote villages, prisons and poor urban neighborhoods who were trained to treat patients with hepatitis C achieved excellent results identical to those of specialists at a university medical center.
Lancet World Report examines how "[d]isappointment over a long-awaited report on improving drug research and development for neglected diseases" led the WHO to form a new Consultative Expert Working Group (CEWG) to strategize around drug research and development. The formation of the new group comes after the report from the previous working group (EWG) was questioned due to "what some perceived to be a missed opportunity, unclear methods, a lack of transparency and signs of industry interference" and after "suspicions of impropriety" surfaced.
A defining hallmark of Alzheimer's disease is the accumulation of the amyloid beta protein (A-beta), otherwise known as "senile plaques," in the brain's cortex and hippocampus, where memory consolidation occurs.
› Verified 7 days ago
| Entity Name | Advanced Access Medical Care, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689014987 PECOS PAC ID: 4082849716 Enrollment ID: O20131104001674 |
News Archive
Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
Under a completely new way of providing health care, primary care clinicians in remote villages, prisons and poor urban neighborhoods who were trained to treat patients with hepatitis C achieved excellent results identical to those of specialists at a university medical center.
Lancet World Report examines how "[d]isappointment over a long-awaited report on improving drug research and development for neglected diseases" led the WHO to form a new Consultative Expert Working Group (CEWG) to strategize around drug research and development. The formation of the new group comes after the report from the previous working group (EWG) was questioned due to "what some perceived to be a missed opportunity, unclear methods, a lack of transparency and signs of industry interference" and after "suspicions of impropriety" surfaced.
A defining hallmark of Alzheimer's disease is the accumulation of the amyloid beta protein (A-beta), otherwise known as "senile plaques," in the brain's cortex and hippocampus, where memory consolidation occurs.
› Verified 7 days ago
| Entity Name | Kidney Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578933461 PECOS PAC ID: 5698071868 Enrollment ID: O20160315000505 |
News Archive
Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
Under a completely new way of providing health care, primary care clinicians in remote villages, prisons and poor urban neighborhoods who were trained to treat patients with hepatitis C achieved excellent results identical to those of specialists at a university medical center.
Lancet World Report examines how "[d]isappointment over a long-awaited report on improving drug research and development for neglected diseases" led the WHO to form a new Consultative Expert Working Group (CEWG) to strategize around drug research and development. The formation of the new group comes after the report from the previous working group (EWG) was questioned due to "what some perceived to be a missed opportunity, unclear methods, a lack of transparency and signs of industry interference" and after "suspicions of impropriety" surfaced.
A defining hallmark of Alzheimer's disease is the accumulation of the amyloid beta protein (A-beta), otherwise known as "senile plaques," in the brain's cortex and hippocampus, where memory consolidation occurs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bashar Ericsoossi, MD 1733 Eastchester Road, Suite 2, Bronx, NY 10461 Ph: (718) 409-2007 | Bashar Ericsoossi, MD 250 E Day Rd Ste 300, Mishawaka, IN 46545-3471 Ph: (574) 968-0283 |
News Archive
Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
Under a completely new way of providing health care, primary care clinicians in remote villages, prisons and poor urban neighborhoods who were trained to treat patients with hepatitis C achieved excellent results identical to those of specialists at a university medical center.
Lancet World Report examines how "[d]isappointment over a long-awaited report on improving drug research and development for neglected diseases" led the WHO to form a new Consultative Expert Working Group (CEWG) to strategize around drug research and development. The formation of the new group comes after the report from the previous working group (EWG) was questioned due to "what some perceived to be a missed opportunity, unclear methods, a lack of transparency and signs of industry interference" and after "suspicions of impropriety" surfaced.
A defining hallmark of Alzheimer's disease is the accumulation of the amyloid beta protein (A-beta), otherwise known as "senile plaques," in the brain's cortex and hippocampus, where memory consolidation occurs.
› Verified 7 days ago
Mini Sra, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Rafat H Ansari, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-234-5123 Fax: 574-282-2813 | |
Dr. Elizabeth Marie Lauber, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Margaret Ann Quate-operacz, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3665 Park Pl W, Suite 300, Mishawaka, IN 46545 Phone: 574-607-4724 Fax: 574-607-4725 | |
Dr. Sayuri Cheruvu, M.B.,B.S Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-237-1328 Fax: 574-237-1348 | |
Anandkumar M Koyani, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 303 S Main St, Suite 109, Mishawaka, IN 46544 Phone: 574-256-0235 Fax: 574-256-0236 | |
Dr. Yufeng Kevin Wu, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 301 E Day Rd, Ste 200, Mishawaka, IN 46545 Phone: 574-204-7252 Fax: 574-968-0468 |